27 March 2024 - PHARMAC is funding two new cancer treatments, one for advanced breast cancer (ribociclib succinate) and one ...
19 March 2024 - Australians living with essential tremor can now access magnetic resonance-guided focused ultrasound through Medicare, with the ...
17 March 2024 - Zymfentra is commercially available across the US on 15 March 2024. ...
15 March 2024 - Pharmac has decided to keep Rule 8.1b, which allows medicines for treating children with cancer to ...
14 March 2024 - Medicare Part D plans statutorily cannot cover anti-obesity medications, but state Medicaid programs have more flexibility. ...
12 March 2024 - Sumitomo Pharma announced today that Orgovyx (relugolix), an oral gonadotropin-releasing hormone receptor antagonist, is now available for ...
11 March 2024 - bluebird bio today announced it has signed its first Medicaid outcomes based agreement for Lyfgenia (lovotibeglogene autotemcel) ...
5 March 2024 - Multiple formulary listings are a step forward to ensuring that post-menopausal women have access to medicines ...
3 March 2024 - Australians with chronic heart failure now have access to cheaper medicines under the PBS. ...
29 February 2024 - Continuing the ongoing implementation of President Biden’s prescription drug pricing law, the Inflation Reduction Act of 2022, ...
29 February 2024 - On Rare Disease Day — a day when the international community raises awareness about rare conditions ...
1 March 2024 - The March 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
1 March 2024 - The March 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
29 February 2024 - PHARMAC understands that people living with rare disorders face many challenges, including access to health care ...
23 February 2024 - A West Coast dad is receiving “outdated treatment” for his leukaemia because PHARMAC’s policies are blocking ...